Concepedia

Fumihiko Hayakawa

FH

52

Publications

3.4K

Citations

30

H-Index

1993

Active since

Affiliations

Nagoya University(Current)

Nagoya Medical Center

National Hospital Organization

Nagoya University Hospital

Otsuka (Japan)

Fumihiko Hayakawa is an author at Nagoya University specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

1993–2022

52

Publications

52

Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines

Fumihiko Hayakawa, Masayuki Towatari, Hitoshi Kiyoi et al. · Oncogene · 2000 · 559 citations

, , +9

Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases

Jianfeng Li, Yuting Dai, Henrik Lilljebjörn et al. · Proceedings of the National Academy of Sciences · 2018 · 300 citations · Full text

A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations

Takeshi Yamaura, Toshiyuki Nakatani, Ken Uda et al. · Blood · 2017 · 143 citations

Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis

Fumihiko Hayakawa, Martin L. Privalsky · Cancer Cell · 2004 · 135 citations · Full text

, , +12

Small‐molecule Hedgehog inhibitor attenuates the leukemia‐initiation potential of acute myeloid leukemia cells

Nobuaki Fukushima, Yosuke Minami, Seiji Kakiuchi et al. · Cancer Science · 2016 · 135 citations · Full text

Rows per page

1–5 of 52